We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSR
3026
Centerspace
CSR
$923M
$35.7K ﹤0.01%
636
-538
-46% -$33.9K
EDIT icon
3027
Editas Medicine
EDIT
$375M
$35.7K ﹤0.01%
11,028
+3,866
+54% +$11.3K
AKBA icon
3028
Akebia Therapeutics
AKBA
$243M
$35.7K ﹤0.01%
31,321
-21,384
-41% -$25.5K
UAMY icon
3029
United States Antimony
UAMY
$642M
$35.7K ﹤0.01%
4,916
-5,646
-53% -$51.1K
MBUU icon
3030
Malibu Boats
MBUU
$454M
$35.7K ﹤0.01%
1,300
-424
-25% -$11.3K
KIDS icon
3031
OrthoPediatrics
KIDS
$583M
$35.7K ﹤0.01%
1,864
+640
+52% +$11.1K
ASC icon
3032
Ardmore Shipping
ASC
$742M
$35.7K ﹤0.01%
2,545
-1,021
-29% -$17.3K
STTK icon
3033
Shattuck Labs
STTK
$616M
$35.6K ﹤0.01%
+5,133
New +$32K
WGO icon
3034
Winnebago Industries
WGO
$756M
$35.6K ﹤0.01%
1,139
-24
-2% -$732
HIPO icon
3035
Hippo Holdings
HIPO
$812M
$35.6K ﹤0.01%
1,259
+181
+17% +$4.81K
MRP
3036
Millrose Properties Inc
MRP
$4.4B
$35.5K ﹤0.01%
1,183
-3,672
-76% -$106K
CTNM
3037
Contineum Therapeutics
CTNM
$490M
$35.5K ﹤0.01%
2,164
+1,433
+196% +$18.8K
SEPN
3038
Septerna Inc
SEPN
$1.82B
$35.5K ﹤0.01%
1,059
+342
+48% +$9.7K
NPB
3039
Northpointe Bancshares
NPB
$523M
$35.5K ﹤0.01%
1,849
+811
+78% +$14.5K
NHP
3040
National Healthcare Properties
NHP
$1.18B
$35.4K ﹤0.01%
+2,416
New +$33.8K
SMC
3041
Summit Midstream
SMC
$420M
$35.3K ﹤0.01%
1,238
-34
-3% -$1.01K
CGC
3042
Canopy Growth
CGC
$391M
$35.2K ﹤0.01%
+37,089
New +$39.4K
FEIM icon
3043
Frequency Electronics
FEIM
$970M
$35.2K ﹤0.01%
531
-212
-29% -$13K
MTRX icon
3044
Matrix Service
MTRX
$270M
$35.2K ﹤0.01%
2,568
-2,018
-44% -$26K
FRAF icon
3045
Franklin Financial Services
FRAF
$280M
$35.2K ﹤0.01%
562
-637
-53% -$36.8K
EU
3046
enCore Energy
EU
$235M
$35.1K ﹤0.01%
26,832
+9,747
+57% +$16.4K
YUMC icon
3047
Yum China
YUMC
$13.9B
$35.1K ﹤0.01%
860
+686
+394% +$31.4K
ENHA
3048
Enhanced Group Inc
ENHA
$212M
$35.1K ﹤0.01%
+12,220
New +$81.6K
PUSA
3049
Aureus Greenway Holdings
PUSA
$105M
$35K ﹤0.01%
+8,781
New +$36.8K
ORRF icon
3050
Orrstown Financial Services
ORRF
$817M
$35K ﹤0.01%
858
-334
-28% -$12.6K

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.